• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于相似性评分的虚拟筛选鉴定水配位HER2抑制剂

Identification of a Water-Coordinating HER2 Inhibitor by Virtual Screening Using Similarity-Based Scoring.

作者信息

Guo Jiaye, Collins Stephen, Miller W Todd, Rizzo Robert C

出版信息

Biochemistry. 2018 Aug 14;57(32):4934-4951. doi: 10.1021/acs.biochem.8b00524. Epub 2018 Jul 30.

DOI:10.1021/acs.biochem.8b00524
PMID:29975516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6110523/
Abstract

Human epidermal growth factor receptor 2 (HER2) is a validated breast cancer drug target for small molecule inhibitors that target the ATP-binding pocket of the kinase domain. In this work, a large-scale virtual screen was performed to a novel homology model of HER2, in a hypothesized "fully active" state, that considered water-mediated interactions during the prioritization of compounds for experimental testing. This screen led to the identification of a new inhibitor with micro molar affinity and potency ( K = 7.0 μM, IC = 4.6 μM). Accompanying molecular dynamics simulations showed that inhibitor binding likely involves water coordination through an important water-mediated network previously identified in our laboratory. The predicted binding geometry also showed a remarkable overlap with the crystallographic poses for two previously reported inhibitors of the related Chk1 kinase. Concurrent with the HER2 studies, we developed formalized computational protocols that leverage solvated footprints (per-residue interaction maps that include bridging waters) to identify ligands that can "coordinate" or "displace" key binding site waters. Proof-of-concept screens targeting HIVPR and PARP1 demonstrate that molecules with high footprint overlap can be effectively identified in terms of their coordination or displacement patterns relative to a known reference. Overall, the procedures developed as a result of this study should be useful for researchers targeting HER2 and, more generally, for any protein in which the identification of compounds that exploit binding site waters is desirable.

摘要

人表皮生长因子受体2(HER2)是一种已获验证的乳腺癌药物靶点,可用于针对激酶结构域ATP结合口袋的小分子抑制剂。在这项研究中,我们对处于假设的“完全活性”状态的HER2新型同源模型进行了大规模虚拟筛选,在化合物优先排序以进行实验测试的过程中考虑了水介导的相互作用。该筛选鉴定出一种具有微摩尔亲和力和效力的新型抑制剂(K = 7.0 μM,IC = 4.6 μM)。伴随的分子动力学模拟表明,抑制剂结合可能通过我们实验室先前鉴定的一个重要水介导网络涉及水配位。预测的结合几何结构还与两种先前报道的相关Chk1激酶抑制剂的晶体学构象显示出显著重叠。在进行HER2研究的同时,我们开发了形式化的计算方案,利用溶剂化足迹(包括桥连水的每个残基相互作用图)来识别能够“配位”或“取代”关键结合位点水的配体。针对HIVPR和PARP1的概念验证筛选表明,就其相对于已知参考物的配位或取代模式而言,可以有效识别具有高足迹重叠的分子。总体而言,这项研究结果所开发的程序对靶向HER2的研究人员应该是有用的,更普遍地说,对于任何希望鉴定利用结合位点水的化合物的蛋白质都是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/af887a10171c/bi-2018-00524z_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/d95eba67c1e5/bi-2018-00524z_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/5a12f9ca5cb8/bi-2018-00524z_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/908bf91c432c/bi-2018-00524z_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/e930bf9be0ec/bi-2018-00524z_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/f4dd81245c85/bi-2018-00524z_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/77c4cd150c3e/bi-2018-00524z_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/3a53740dae8d/bi-2018-00524z_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/be287a242655/bi-2018-00524z_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/db6a2f59d14c/bi-2018-00524z_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/aab4d18864a5/bi-2018-00524z_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/793673d05d28/bi-2018-00524z_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/27aa2879f866/bi-2018-00524z_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/5afc45bd18ff/bi-2018-00524z_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/10cf1088eb46/bi-2018-00524z_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/75d6ebfa7fce/bi-2018-00524z_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/e37db2446fa8/bi-2018-00524z_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/af887a10171c/bi-2018-00524z_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/d95eba67c1e5/bi-2018-00524z_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/5a12f9ca5cb8/bi-2018-00524z_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/908bf91c432c/bi-2018-00524z_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/e930bf9be0ec/bi-2018-00524z_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/f4dd81245c85/bi-2018-00524z_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/77c4cd150c3e/bi-2018-00524z_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/3a53740dae8d/bi-2018-00524z_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/be287a242655/bi-2018-00524z_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/db6a2f59d14c/bi-2018-00524z_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/aab4d18864a5/bi-2018-00524z_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/793673d05d28/bi-2018-00524z_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/27aa2879f866/bi-2018-00524z_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/5afc45bd18ff/bi-2018-00524z_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/10cf1088eb46/bi-2018-00524z_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/75d6ebfa7fce/bi-2018-00524z_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/e37db2446fa8/bi-2018-00524z_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c9/6110523/af887a10171c/bi-2018-00524z_0017.jpg

相似文献

1
Identification of a Water-Coordinating HER2 Inhibitor by Virtual Screening Using Similarity-Based Scoring.基于相似性评分的虚拟筛选鉴定水配位HER2抑制剂
Biochemistry. 2018 Aug 14;57(32):4934-4951. doi: 10.1021/acs.biochem.8b00524. Epub 2018 Jul 30.
2
In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2.计算机辅助设计:针对 EGFR 和 HER2 的新型双重作用抑制剂的扩展分子动力学模拟。
J Mol Graph Model. 2013 Jul;44:220-31. doi: 10.1016/j.jmgm.2013.06.004. Epub 2013 Jul 3.
3
3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors.基于三维药效团的虚拟筛选、对接及密度泛函理论方法用于发现新型人表皮生长因子受体2(HER2)抑制剂
J Theor Biol. 2016 Dec 21;411:68-80. doi: 10.1016/j.jtbi.2016.09.016. Epub 2016 Sep 28.
4
Comparative anti-proliferative effects of potential HER2 inhibitors on a panel of breast cancer cell lines.比较潜在 HER2 抑制剂对一组乳腺癌细胞系的抗增殖作用。
Breast Cancer. 2020 Mar;27(2):213-224. doi: 10.1007/s12282-019-01011-z. Epub 2019 Sep 26.
5
Identification of novel chemical scaffolds against kinase domain of cancer causing human epidermal growth factor receptor 2: a systemic chemoinformatic approach.针对致癌人类表皮生长因子受体 2 激酶结构域的新型化学支架的鉴定:系统化学信息学方法。
J Biomol Struct Dyn. 2024 Aug;42(12):6269-6279. doi: 10.1080/07391102.2023.2233618. Epub 2023 Jul 9.
6
Combination of In Silico Analysis and In Vitro Assay to Investigate Drug Response to Human Epidermal Growth Factor Receptor 2 Mutations in Lung Cancer.整合计算机分析与体外试验以研究肺癌中人类表皮生长因子受体2突变的药物反应
Mol Inform. 2016 Jan;35(1):25-35. doi: 10.1002/minf.201500030. Epub 2015 Oct 21.
7
A systematic analysis of the resistance and sensitivity of HER2YVMA receptor tyrosine kinase mutant to tyrosine kinase inhibitors in HER2-positive lung cancer.HER2阳性肺癌中HER2YVMA受体酪氨酸激酶突变体对酪氨酸激酶抑制剂的耐药性和敏感性的系统分析。
J Recept Signal Transduct Res. 2016;36(1):89-97. doi: 10.3109/10799893.2015.1049361. Epub 2015 Sep 22.
8
Computational analyses of curcuminoid analogs against kinase domain of HER2.针对 HER2 激酶结构域的姜黄素类似物的计算分析。
BMC Bioinformatics. 2014 Aug 3;15(1):261. doi: 10.1186/1471-2105-15-261.
9
Strategies for lead discovery: application of footprint similarity targeting HIVgp41.先导化合物发现策略:基于足迹相似性靶向HIV gp41的应用
Bioorg Med Chem. 2014 Jan 1;22(1):651-61. doi: 10.1016/j.bmc.2013.10.022. Epub 2013 Oct 26.
10
Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of through molecular dynamics and pharmacophore-based screening.通过分子动力学和基于药效团的筛选,开发源自黄酮类化合物的新型抗胃癌HER2抑制剂。
Drug Des Devel Ther. 2016 Nov 4;10:3611-3632. doi: 10.2147/DDDT.S111914. eCollection 2016.

引用本文的文献

1
Screening, docking, and molecular dynamics analysis of Mitragyna speciosa (Korth.) compounds for targeting HER2 in breast cancer.用于靶向乳腺癌中HER2的帽柱木属植物化合物的筛选、对接及分子动力学分析。
Curr Res Struct Biol. 2025 Jun 20;10:100171. doi: 10.1016/j.crstbi.2025.100171. eCollection 2025 Dec.
2
A molecular evolution algorithm for ligand design in DOCK.DOCK 中配体设计的分子进化算法。
J Comput Chem. 2022 Nov 5;43(29):1942-1963. doi: 10.1002/jcc.26993. Epub 2022 Sep 8.
3
Inhibition of mutationally activated HER2.抑制突变激活的 HER2。

本文引用的文献

1
Kinase inhibitors: the road ahead.激酶抑制剂:前路漫漫。
Nat Rev Drug Discov. 2018 May;17(5):353-377. doi: 10.1038/nrd.2018.21. Epub 2018 Mar 16.
2
Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets.可定制的从头设计策略 DOCK:在 HIVgp41 和其他治疗靶标中的应用。
J Comput Chem. 2017 Nov 15;38(30):2641-2663. doi: 10.1002/jcc.25052. Epub 2017 Sep 22.
3
The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.抗伤害感受剂SBFI-26在两个不同位点与花生四烯乙醇胺转运蛋白FABP5和FABP7结合。
Chem Biol Drug Des. 2023 Jan;101(1):87-102. doi: 10.1111/cbdd.14125. Epub 2022 Aug 27.
4
Outliers in SAR and QSAR: 3. Importance of considering the role of water molecules in protein-ligand interactions and quantitative structure-activity relationship studies.SAR和QSAR中的异常值:3. 考虑水分子在蛋白质-配体相互作用和定量构效关系研究中的作用的重要性。
J Comput Aided Mol Des. 2021 Mar;35(3):371-396. doi: 10.1007/s10822-021-00377-7. Epub 2021 Mar 13.
5
Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E.基于同源建模和基于相似性的筛选技术鉴定寨卡病毒抑制剂以靶向糖蛋白 E
Biochemistry. 2020 Oct 6;59(39):3709-3724. doi: 10.1021/acs.biochem.0c00458. Epub 2020 Sep 17.
6
Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening.通过基于相似性的筛选鉴定脂肪酸结合蛋白 5 抑制剂。
Biochemistry. 2019 Oct 22;58(42):4304-4316. doi: 10.1021/acs.biochem.9b00625. Epub 2019 Oct 11.
Biochemistry. 2017 Jul 11;56(27):3454-3462. doi: 10.1021/acs.biochem.7b00194. Epub 2017 Jun 28.
4
Structure-based identification of inhibitors targeting obstruction of the HIVgp41 N-heptad repeat trimer.基于结构的靶向HIV gp41 N-七肽重复三聚体阻断的抑制剂鉴定
Bioorg Med Chem Lett. 2017 Jul 15;27(14):3177-3184. doi: 10.1016/j.bmcl.2017.05.020. Epub 2017 May 8.
5
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的狂喜与痛苦
ACS Cent Sci. 2017 Mar 22;3(3):143-147. doi: 10.1021/acscentsci.7b00069. Epub 2017 Feb 28.
6
Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity.通过足迹相似性鉴定肉毒杆菌神经毒素血清型E的小分子抑制剂
Bioorg Med Chem. 2016 Oct 15;24(20):4875-4889. doi: 10.1016/j.bmc.2016.07.031. Epub 2016 Jul 18.
7
Water, water, everywhere… It's time to stop and think.水,水,到处都是水…… 是时候停下来思考一下了。
Drug Discov Today. 2016 Jul;21(7):1139-46. doi: 10.1016/j.drudis.2016.05.009. Epub 2016 May 19.
8
Docking Screens for Novel Ligands Conferring New Biology.用于赋予新生物学特性的新型配体的对接筛选
J Med Chem. 2016 May 12;59(9):4103-20. doi: 10.1021/acs.jmedchem.5b02008. Epub 2016 Mar 15.
9
ZINC 15--Ligand Discovery for Everyone.锌15——面向大众的配体发现平台。
J Chem Inf Model. 2015 Nov 23;55(11):2324-37. doi: 10.1021/acs.jcim.5b00559. Epub 2015 Nov 9.
10
PubChem Substance and Compound databases.美国国立医学图书馆化学物质数据库和化合物数据库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1202-13. doi: 10.1093/nar/gkv951. Epub 2015 Sep 22.